COVID Focus Talk || Ivermectin Pharmacological Considerations || Is this drug suitable for everyone?
#ivermectin #ivermectinpharmacology #ivermectininteraction
Hi everyone! This week let's have a focused pharmacological/ pharmaceutical talk on the ivermectin. Its mechanism as an antiviral, pharmacokinetics, and drug interactions.
If you appreciate my work, you can buy me a coffee :)
https://www.buymeacoffee.com/dr2hong
Disclaimer:
This video is Dr. Hong’s interpretation and summary of publically available scientific information
This video is not intended to serve as any advice regarding the treatment, prevention, and diagnosis of any diseases
Dr. Hong has no connections and receives no monetary compensation from any pharmaceutical companies and government.
This video is for educational purposes only.
__________
COVID Focus Talk || Ivermectin use in COVID || Meta-analysis Digest in 6-min || What is the verdict?
https://youtu.be/4ORnok3Jyo8
COVID Focus Talk || What We Know about Vaccine in Immunocompromised Patients || Safety & Efficacy
https://youtu.be/qIhGmJbKENA
COVID Focus Talk || Will you wait for the Novavax vaccine? || 5 Facts of Novavax You Must Know
https://youtu.be/t-TOT568yZ4
--------------------------------
Source References
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
https://www.sciencedirect.com/science/article/pii/S0166354220302011
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID‐19
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404744/
The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article
https://www.nature.com/articles/s41429-021-00430-5
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365923/
Dexamethasone in Hospitalized Patients with Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMoa2021436
PRINCIPLE Trial
https://www.principletrial.org/news/ivermectin-to-be-investigated-as-a-possible-treatment-for-covid-19-in-oxford2019s-principle-trial
Coagulation abnormalities and ivermectin
https://pubmed.ncbi.nlm.nih.gov/1449278/
A Case of Ivermectin-Induced Warfarin Toxicity: First Published Report
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293392/
Видео COVID Focus Talk || Ivermectin Pharmacological Considerations || Is this drug suitable for everyone? канала Dr. Hong's Pharmacy Classroom
Hi everyone! This week let's have a focused pharmacological/ pharmaceutical talk on the ivermectin. Its mechanism as an antiviral, pharmacokinetics, and drug interactions.
If you appreciate my work, you can buy me a coffee :)
https://www.buymeacoffee.com/dr2hong
Disclaimer:
This video is Dr. Hong’s interpretation and summary of publically available scientific information
This video is not intended to serve as any advice regarding the treatment, prevention, and diagnosis of any diseases
Dr. Hong has no connections and receives no monetary compensation from any pharmaceutical companies and government.
This video is for educational purposes only.
__________
COVID Focus Talk || Ivermectin use in COVID || Meta-analysis Digest in 6-min || What is the verdict?
https://youtu.be/4ORnok3Jyo8
COVID Focus Talk || What We Know about Vaccine in Immunocompromised Patients || Safety & Efficacy
https://youtu.be/qIhGmJbKENA
COVID Focus Talk || Will you wait for the Novavax vaccine? || 5 Facts of Novavax You Must Know
https://youtu.be/t-TOT568yZ4
--------------------------------
Source References
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
https://www.sciencedirect.com/science/article/pii/S0166354220302011
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID‐19
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404744/
The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article
https://www.nature.com/articles/s41429-021-00430-5
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365923/
Dexamethasone in Hospitalized Patients with Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMoa2021436
PRINCIPLE Trial
https://www.principletrial.org/news/ivermectin-to-be-investigated-as-a-possible-treatment-for-covid-19-in-oxford2019s-principle-trial
Coagulation abnormalities and ivermectin
https://pubmed.ncbi.nlm.nih.gov/1449278/
A Case of Ivermectin-Induced Warfarin Toxicity: First Published Report
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293392/
Видео COVID Focus Talk || Ivermectin Pharmacological Considerations || Is this drug suitable for everyone? канала Dr. Hong's Pharmacy Classroom
Показать
Комментарии отсутствуют
Информация о видео
5 июля 2021 г. 4:00:01
00:09:34
Другие видео канала
Ivermectin And COVID-19 Prevention: 83% Decrease In Infections With Ivermectin Prophylaxis?A third dose of mRNA vaccines | Why and Why not? | 5 Facts you must know before decidingWho are sick with Omicron variant (so far)? 4-minute Update, Nov 29thWhy natural immunity does not count in US? Where is the logic? Immune vs non-ImmuneFDA Advisory Committee vs Pfizer | Why voted NO for the booster dose? 11 min digest you must know!Ivermectin, Mexico, Peru, IndiaNew Pfizer drug and ivermectinShould I Prescribe Ivermectin for COVID? | Ivermectin Update 2021Africa, better than US and UKCOVID Focus Talk || Will you wait for the Novavax vaccine? || 5 Facts of Novavax You Must KnowSome doctors want Ivermectin approved for COVID-19 treatmentDr Natrajan @Supreme Hospital - Ivermectin significantly reduce viral load time in COVID19 patientsVaccine or Drug (Immunotherapy)? Definition of a vaccineIvermectin or MolnupiravirOmicron Variant of Concern | 5-minute highlights on key pointsNews Roundup | Mexico City Population-Level Study Administers Ivermectin-based Home KitsHome ivermectin based kits in IndiaICON Study: Use of Ivermectin in Hospitalized Patients With COVID-19 | January 2021 Journal Club‘Immunocompromised Patients’ Response to COVID Vaccines – The OCTAVE study explainedCOVID Focus Talk || Ivermectin use in COVID || Meta-analysis Digest in 6-min || What is the verdict?